
Zunaglim M 2mg/500mg Tablet
Marketer
Zunarsh Lifesciences Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg)
Overview Zunaglim M 2mg/500mg Tablet
Diabetam Duo 2mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabetam Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive diabetes management plan, including a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices are essential for diabetes control. Hypoglycemia (low blood sugar) is a prevalent side effect, manifested by symptoms like sweating, lightheadedness, headache, and tremors. Learn to recognize and treat these symptoms; maintain regular meals and carry a rapid-acting glucose source (e.g., sugary snacks or juice). Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart conditions should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring is necessary, and your doctor might recommend blood tests to assess blood cell counts and liver function.
Uses of Zunaglim M 2mg/500mg Tablet
Managing type 2 diabetes
Major Benefits of Zunaglim M 2mg/500mg Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the Zunaglim M 2mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Zunaglim M 2mg/500mg Tablet:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Zunaglim M 2mg/500mg Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Zunaglim M 2mg/500mg Tablet with a meal.
How Zunaglim M 2mg/500mg Tablet works:
Each Zunaglim M 2mg/500mg tablet contains glimepiride (a sulfonylurea) and metformin (a biguanide), two medications that manage blood sugar. Glimepiride stimulates the pancreas to release more insulin, thus reducing blood glucose levels. Metformin's action is threefold: it decreases hepatic glucose production, slows intestinal glucose absorption, and enhances insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Zunaglim M 2mg/500mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Zunaglim M 2mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingUNSAFE
Lactation and Zunaglim M 2mg/500mg tablets are incompatible. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Zunaglim M 2mg/500mg tablets, potentially requiring dosage modification. Physician consultation is recommended. This medication is contraindicated in individuals with severe kidney disease. Regular monitoring of renal function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use Zunaglim M 2mg/500mg tablets cautiously, potentially requiring dosage modification. Consultation with a physician is advised. For those with mild to moderate liver disease, a low initial dose is typically prescribed; however, the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Zunaglim M 2mg/500mg Tablet :
Should you forget to take your Zunaglim M 2mg/500mg Tablet, administer it immediately. If, however, your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Never take a double dose.
Facts to Know About Zunaglim M 2mg/500mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
